Stock listing

Brain Biotech Ag

Selected listing: BNND · AQUISUK · EUR · GB

Brain Biotech Ag (Aquis:BNND), Health Technology. Latest release Sep 9, 2026: BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty…

BNND:AQUISUKEURGBUpdated September 25, 2026

Ticker: Aquis:BNND
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Aquis
Currency: EUR

About Brain Biotech Ag

The company focuses on innovative biotechnological solutions, contributing to advancements in the field. As a publicly listed entity, Brain Biotech AG is committed to transparency and regulatory compliance in its operations.

Latest news from Brain Biotech Ag

BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma

September 9, 2026

BRAIN Biotech reports its 9M results and continues to target a break-even adjusted Group-EBITDA

August 27, 2026

Dr. Sven K. Weber Succeeds Adriaan Moelker as CEO of BRAIN Biotech AG

July 29, 2026

BRAIN Biotech AG signs new Revolving Credit Facility with MP Beteiligungs-GmbH

July 13, 2026

BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance

May 28, 2026

All Brain Biotech Ag news →

Research Brain Biotech Ag

Brain Biotech Ag company profile

View the public company page for Brain Biotech Ag on 6ix.

Brain Biotech Ag news

Read company news and market updates connected to Brain Biotech Ag.

Brain Biotech Ag investor events

Find investor webinars, events, and replay context for Brain Biotech Ag.